Pressroom

WHO Approves New Child Vaccine, Crucell Shares Up

By: ten Wolde, Harro

09/26/2006

The World Health Organization (WHO) has prequalified Dutch biotech firm Crucell to start selling a new vaccine, developed through its licensed human cell platform, that protects against diphtheria, tetanus, whooping cough, hepatitis B, and Haemophilus influenzae type b in children. The prequalification decision means Quinvaxem will be available for sale to UNICEF and the Pan American Health Organization.

In This Section

Diseases Prevented by Vaccines

State Requirements

Anthrax	Diphtheria	Haemophilus Influenzae type b (Hib)
Hepatitis A	Hepatitis B	Human Papillomavirus (HPV)
Influenza	Japanese Encephalitis	Lyme Disease
Measles	Meningococcal	Mumps
Pertussis (Whooping Cough)	Pneumococcal Disease	Polio
Rabies	Rotavirus	Rubella
Shingles (Herpes Zoster)	Smallpox	Tetanus
Tuberculosis	Typhoid Fever	Varicella (Chickenpox)
Yellow Fever